GlassScriptPhysician profile
Maria C Bell
NPI 1477181279
$1,821.35
in general payments reported to CMS, 2019-2025
22 companies · $931 in 2025
The $931 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $97.62 · 2023: $125 · 2024: $668 · 2025: $931.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,724.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,723.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $220.74 | 2024-2025 | Nemluvio, Aklief |
| Abbvie INC. | $213.50 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $206.02 | 2022-2024 | Spevigo |
| Amgen INC. | $178.69 | 2024-2025 | Otezla, Otezla |
| Novartis Pharmaceuticals Corporation | $160.81 | 2024-2025 | |
| Krystal Biotech INC | $125.00 | 2023 | Vyjuvek |
| Incyte Corporation | $113.19 | 2024-2025 | Opzelura |
| Ucb, INC. | $97.91 | 2024-2025 | Bimzelx |
| Pfizer INC. | $87.34 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $77.38 | 2025 | Dupixent, Libtayo |
| Lilly USA, LLC | $55.29 | 2024-2025 | Olumiant, Taltz, Ebglyss |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $54.05 | 2025 | Cabtreo, Jublia, Siliq |
| E.R. Squibb & Sons, L.L.C. | $51.60 | 2024-2025 | Sotyktu |
| Arcutis Biotherapeutics, INC. | $29.89 | 2024-2025 | Zoryve |
| Octapharma USA, INC. | $24.10 | 2025 | Octagam Immune Globulin (Human) |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $23.86 | 2025 | Tremfya |
| Mayne Pharma Commercial LLC | $19.59 | 2025 | |
| Genzyme Corporation | $19.20 | 2024 | |
| Biofrontera INC. | $17.80 | 2024 | Xepi, Bf-Rhodoled, Ameluz |
| Integra Lifesciences Corporation | $16.24 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Convatec INC. | $15.05 | 2024 | |
| Leo Pharma INC. | $14.10 | 2025 | Adbry |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Bell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.